Pyxis Oncology, Inc. (NASDAQ:PYXS) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Freda Lewis-Hall Other companies: CDT Equity Inc. (Director · Since at least Sep 22, 2023); SpringWorks Therapeutics Inc (Director · Since at least Mar 29, 2019); EXACT Sciences Corporation (Director · Apr 22, 2020 – Jun 8, 2023 · Past); 1Life Healthcare Inc (Director · Jan 30, 2020 – Feb 22, 2023 · Past); Pfizer, Inc. (Executive Vice President · Feb 22, 2018 – Feb 27, 2019 · Past) | Director · Since at least Oct 7, 2021 |
| Darren Cline Other companies: Xenon Pharmaceuticals Inc. (Chief Commercial Officer · Since at least Jun 23, 2025); Pliant Therapeutics, Inc. (Board Member · Since at least Jun 13, 2024) | Director · Since at least Mar 26, 2024 |
| Rachel Humphrey Other companies: Xilio Therapeutics, Inc. (Director · Oct 21, 2021 – Oct 21, 2021 · Past); Black Diamond Therapeutics, Inc. (Chief Medical Officer · Feb 17, 2021 – Feb 17, 2021 · Past) | Director · Since at least Aug 11, 2022 |
| John Flavin Other companies: Advanced Life Sciences Holdings Inc (President /Chief Financial Off, Director · Mar 10, 2006 – Aug 16, 2010 · Past) | Lead Independent Director · Since at least Oct 7, 2021 |
| Michael A. Metzger Other companies: Syndax Pharmaceuticals, Inc. (Chief Executive Officer and Director · Since at least Jul 16, 2025) | Director · Since at least Mar 31, 2025 |
| Santhosh Palani Other companies: Acrivon Therapeutics, Inc. (Director · Since at least Mar 4, 2024) | Director · Since at least Mar 12, 2024 |
| Thomas Civik Other companies: Repare Therapeutics Inc (Director · Since at least Jun 17, 2024) | Chief Executive Officer and Chairman of the Board · Since at least Mar 26, 2024 |
| Alex Kane | Senior Vice President, Investor Relations & Capital Markets · Oct 9, 2025 – Nov 5, 2026 · Past |
| Jakob Dupont | Director · Since at least Jul 2, 2026 |
| Jay Feingold | Chief Medical Officer · Oct 7, 2021 – Mar 24, 2023 · Past |
| Jitendra Wadhane | Prin Fin & Acct Officer · Since at least Aug 3, 2022 |
| Joel Edwards | Chief Business Officer · Oct 1, 2025 – Nov 5, 2026 · Past |
| Ken Kobayashi | Chief Medical Officer · Nov 27, 2023 – Dec 29, 2023 · Past |
| Nelson Azoulay | Chief Business Officer · Since at least May 7, 2026 |
| Pyxis Oncology ContactPamela Connealy | CFO and COO · Feb 4, 2025 – Nov 5, 2026 · Past |
| Ronald Herbst | Chief Scientific Officer · Oct 7, 2021 – Oct 7, 2021 · Past |